Keywords: Sanofi Pasteur, Sanofi-Aventis, GlaxoSmithKline, Merck & Co, Menactra, Lamictalm Combination vaccine, Ph III

US FDA approves Sanofi-Pasteur’s Menactra for infants and extends GSK’s Lamictal use; Merck/Sanofi combo vaccine moves into Ph III

Article | 26 April 2011

Print This

The US Food and Drug Administration on Friday approved the use of Sanofi-Aventis (Euronext: SAN) vaccine unit Sanofi Pasteur’ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in